MGAT3 and breast cancer: Tissue microarray (TMA) analysis revealed that MGAT3 and bisecting GlcNAc levels were greatly suppressed in recurrent BC patients (Fig. 1E&F), and higher MGAT3 and bisecting GlcNAc levels correlated with improved overall survival and disease-free survival (Fig. 1G&H).